Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS)

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53746

language	eng
Author	Nagai Yoji Foundation for Biomedical Research and Innovation Translational Research Informatics Center, Kobe, Japan Kohriyama Tatsuo Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan Origasa Hideki Division of Biostatistics and Clinical Epidemiology, University of Toyama School of Medicine, Toyama, Japan Minematsu Kazuo National Cerebral and Cardiovascular Center, Suita, Japan Yokota Chiaki Department of Cerebrovascular Disease, National Cerebral and Cardiovascular Center, Suita, Japan Uchiyama Shinichiro Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan Ibayashi Setsuro Seiai Rehabilitation Hospital, Ohnojo, Japan Terayama Yasuo Department of Neurology, Iwate Medical University, Morioka, Japan Takagi Makoto Department of Neurology, Tokyo Saiseikai Central Hospital, Tokyo, Japan Kitagawa Kazuo Department of Neurology, Stroke Center, Graduate School of Medicine Osaka University, Suita, Japan Nomura Eiichi Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan Hosomi Naohisa Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan Ohtsuki Toshiho Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan Yamawaki Takemori Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan Matsubara Yoshihiro Foundation for Biomedical Research and Innovation Translational Research Informatics Center, Kobe, Japan Nakamura Masakazu Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan Yamasaki Yoshimitsu Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan Mori Etsuro Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Japan Fukushima Masanori Foundation for Biomedical Research and Innovation Translational Research Informatics Center, Kobe, Japan Kobayashi Shotai Shimane University Faculty of Medicine, Matsue, Japan Shinohara Yukito Department of Neurology, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Tokyo, Japan Yamaguchi Takenori National Cerebral and Cardiovascular Center, Suita, Japan Matsumoto Masayasu Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan
Subject	recurrence; secondary prevention; statins; stroke
Journal Title	INTERNATIONAL JOURNAL OF STROKE
Volume	9
Issue	2
Start Page	232
End Page	239
ISSN	1747-4930
ISSN（Online）	1747-4949
Published Date	2014-02
DOI	10.1111/ijs.12099
PubMed ID	24015915
Publisher	SAGE PUBLICATIONS LTD
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This study was supported through a grant from the Ministry of Health, Labour and Welfare of Japan. After the period of governmental support expired, the study was conducted in collaboration with Hiroshima University Medical School and the Foundation for Biomedical Research and Innovation. The latter organization receives unconditional research grants from several pharmaceutical companies, including DAIICHI SANKYO CO., LTD., which is commercializing pravastatin. However, the company was not involved in the design and execution of this study. In addition, the company did not provide pravastatin for this study and has not reviewed the current manuscript.